LMAT Quote, Financials, Valuation and Earnings

Integra Lifesciences Holdings has a net margin of 18.39% compared to LeMaitre Vascular's net margin of -6.61%. LeMaitre Vascular's return on equity of 13.74% beat Integra Lifesciences Holdings's return on equity of -1.88%.

LeMaitre Vascular has a consensus price target of $104.50, signalling upside risk potential of 25.42%. On the other hand Integra Lifesciences Holdings has an analysts' consensus of $16.13 which suggests that it could grow by 16.17%. Given that LeMaitre Vascular has higher upside potential than Integra Lifesciences Holdings, analysts believe LeMaitre Vascular is more attractive than Integra Lifesciences Holdings.

LeMaitre Vascular has a beta of 0.827, which suggesting that the stock is 17.35% less volatile than S&P 500. In comparison Integra Lifesciences Holdings has a beta of 1.164, suggesting its more volatile than the S&P 500 by 16.396%.

LeMaitre Vascular has a quarterly dividend of $0.20 per share corresponding to a yield of 0.86%. Integra Lifesciences Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LeMaitre Vascular pays 32.65% of its earnings as a dividend. Integra Lifesciences Holdings pays out -- of its earnings as a dividend. LeMaitre Vascular's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

LeMaitre Vascular quarterly revenues are $59.9M, which are smaller than Integra Lifesciences Holdings quarterly revenues of $382.7M. LeMaitre Vascular's net income of $11M is higher than Integra Lifesciences Holdings's net income of -$25.3M. Notably, LeMaitre Vascular's price-to-earnings ratio is 42.08x while Integra Lifesciences Holdings's PE ratio is 70.14x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LeMaitre Vascular is 8.42x versus 0.66x for Integra Lifesciences Holdings. Usually stocks with elevated PS ratios are considered overvalued.

Intuitive Surgical has a net margin of 18.39% compared to LeMaitre Vascular's net margin of 30.99%. LeMaitre Vascular's return on equity of 13.74% beat Intuitive Surgical's return on equity of 15.82%.

LeMaitre Vascular has a consensus price target of $104.50, signalling upside risk potential of 25.42%. On the other hand Intuitive Surgical has an analysts' consensus of $578.17 which suggests that it could grow by 9.89%. Given that LeMaitre Vascular has higher upside potential than Intuitive Surgical, analysts believe LeMaitre Vascular is more attractive than Intuitive Surgical.

LeMaitre Vascular has a beta of 0.827, which suggesting that the stock is 17.35% less volatile than S&P 500. In comparison Intuitive Surgical has a beta of 1.669, suggesting its more volatile than the S&P 500 by 66.875%.

LeMaitre Vascular has a quarterly dividend of $0.20 per share corresponding to a yield of 0.86%. Intuitive Surgical offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LeMaitre Vascular pays 32.65% of its earnings as a dividend. Intuitive Surgical pays out -- of its earnings as a dividend. LeMaitre Vascular's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

LeMaitre Vascular quarterly revenues are $59.9M, which are smaller than Intuitive Surgical quarterly revenues of $2.3B. LeMaitre Vascular's net income of $11M is lower than Intuitive Surgical's net income of $698.4M. Notably, LeMaitre Vascular's price-to-earnings ratio is 42.08x while Intuitive Surgical's PE ratio is 77.15x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LeMaitre Vascular is 8.42x versus 21.92x for Intuitive Surgical. Usually stocks with elevated PS ratios are considered overvalued.

Masimo has a net margin of 18.39% compared to LeMaitre Vascular's net margin of -45.89%. LeMaitre Vascular's return on equity of 13.74% beat Masimo's return on equity of -39.91%.

LeMaitre Vascular has a consensus price target of $104.50, signalling upside risk potential of 25.42%. On the other hand Masimo has an analysts' consensus of $182.07 which suggests that it could grow by 5.93%. Given that LeMaitre Vascular has higher upside potential than Masimo, analysts believe LeMaitre Vascular is more attractive than Masimo.

LeMaitre Vascular has a beta of 0.827, which suggesting that the stock is 17.35% less volatile than S&P 500. In comparison Masimo has a beta of 1.187, suggesting its more volatile than the S&P 500 by 18.725%.

LeMaitre Vascular has a quarterly dividend of $0.20 per share corresponding to a yield of 0.86%. Masimo offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. LeMaitre Vascular pays 32.65% of its earnings as a dividend. Masimo pays out -- of its earnings as a dividend. LeMaitre Vascular's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

LeMaitre Vascular quarterly revenues are $59.9M, which are smaller than Masimo quarterly revenues of $372M. LeMaitre Vascular's net income of $11M is higher than Masimo's net income of -$170.7M. Notably, LeMaitre Vascular's price-to-earnings ratio is 42.08x while Masimo's PE ratio is 116.80x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LeMaitre Vascular is 8.42x versus 4.72x for Masimo. Usually stocks with elevated PS ratios are considered overvalued.

Teleflex has a net margin of 18.39% compared to LeMaitre Vascular's net margin of 13.56%. LeMaitre Vascular's return on equity of 13.74% beat Teleflex's return on equity of 3.41%.

LeMaitre Vascular has a consensus price target of $104.50, signalling upside risk potential of 25.42%. On the other hand Teleflex has an analysts' consensus of $155.92 which suggests that it could grow by 26.49%. Given that Teleflex has higher upside potential than LeMaitre Vascular, analysts believe Teleflex is more attractive than LeMaitre Vascular.

LeMaitre Vascular has a beta of 0.827, which suggesting that the stock is 17.35% less volatile than S&P 500. In comparison Teleflex has a beta of 1.098, suggesting its more volatile than the S&P 500 by 9.761%.

LeMaitre Vascular has a quarterly dividend of $0.20 per share corresponding to a yield of 0.86%. Teleflex offers a yield of 1.1% to investors and pays a quarterly dividend of $0.34 per share. LeMaitre Vascular pays 32.65% of its earnings as a dividend. Teleflex pays out 91.2% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

LeMaitre Vascular quarterly revenues are $59.9M, which are smaller than Teleflex quarterly revenues of $700.7M. LeMaitre Vascular's net income of $11M is lower than Teleflex's net income of $95M. Notably, LeMaitre Vascular's price-to-earnings ratio is 42.08x while Teleflex's PE ratio is 38.89x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for LeMaitre Vascular is 8.42x versus 1.91x for Teleflex. Usually stocks with elevated PS ratios are considered overvalued.